Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-26 @ 4:01 PM
Ignite Modification Date: 2025-12-26 @ 4:01 PM
NCT ID: NCT05146206
Description: Adverse events data were not collected in this online observational survey as there were no open-text fields.
Frequency Threshold: 0
Time Frame: None
Study: NCT05146206
Study Brief: Patient Satisfaction and Sensory Attributes Allergic Rhinitis Nasal Spray
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Patients on RYALTRIS Patients who are currently using RYALTRIS nasal spray. Observational: In this observational study, participants initated on RYALTRIS/DYMISTA nasal spray will complete a cross-sectional online survey that includes a Best-Worst Scaling task to capture their satisfaction and importance of various treatment attributes. 0 None 0 0 0 0 View
Patients on DYMISTA Patients who are currently using DYMISTA nasal spray. Observational: In this observational study, participants initated on RYALTRIS/DYMISTA nasal spray will complete a cross-sectional online survey that includes a Best-Worst Scaling task to capture their satisfaction and importance of various treatment attributes. 0 None 0 0 0 0 View
Serious Events(If Any):
Other Events(If Any):